Latest news
Loading news…
Avilar Therapeutics
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Waltham, Massachusetts, United States Founded 2020 11-50 employees For Profit
Avilar Therapeutics is a biopharmaceutical company focusing on extracellular protein degradation.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
16
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 3
- IT spend
- $230K
Company Info
- Founded
- 2020
- Employees
- 11-50
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 2
- News articles
- 21
- HQ
- Waltham, Massachusetts, United States
- Region
- Greater Boston Area, East Coast, New England
Signals & Scores
- Heat score
- High
- Growth score
- Low
- Trend (7d)
- 0.5
- Trend (30d)
- 0.3
- Trend (90d)
- -0.3
- Last leadership hire
- Jun 15, 2022
Key People at Avilar Therapeutics
SVP, Chief Development Officer
Chief Business Officer
Founder, CEO & President
16
professional contacts at Avilar Therapeutics
Contact execs at Avilar Therapeutics →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Avilar Therapeutics
Loading news…
FAQs about Avilar Therapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.